Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Eton Pharmaceuticals (ETON) Shares Outstanding (Weighted Average): 2018-2024

Historic Shares Outstanding (Weighted Average) for Eton Pharmaceuticals (ETON) over the last 7 years, with Dec 2024 value amounting to $25.8 million.

  • Eton Pharmaceuticals' Shares Outstanding (Weighted Average) rose 3.80% to $26.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.8 million, marking a year-over-year increase of 3.80%. This contributed to the annual value of $25.8 million for FY2024, which is 0.69% up from last year.
  • Eton Pharmaceuticals' Shares Outstanding (Weighted Average) amounted to $25.8 million in FY2024, which was up 0.69% from $25.7 million recorded in FY2023.
  • Eton Pharmaceuticals' Shares Outstanding (Weighted Average)'s 5-year high stood at $25.8 million during FY2024, with a 5-year trough of $24.2 million in FY2020.
  • Moreover, its 3-year median value for Shares Outstanding (Weighted Average) was $25.7 million (2023), whereas its average is $25.6 million.
  • Data for Eton Pharmaceuticals' Shares Outstanding (Weighted Average) shows a peak YoY skyrocketed of 35.98% (in 2020) over the last 5 years.
  • Eton Pharmaceuticals' Shares Outstanding (Weighted Average) (Yearly) stood at $24.2 million in 2020, then increased by 1.62% to $24.6 million in 2021, then climbed by 2.81% to $25.3 million in 2022, then climbed by 1.43% to $25.7 million in 2023, then increased by 0.69% to $25.8 million in 2024.